Neurodegenerative diseases demand robust diagnostic and therapeutic solutions. At Abyssinia we’re transforming the world’s understanding of Alzheimer’s Disease, from diagnostic assays with the potential for early detection, to treatment paradigms targeting novel disease drivers. Our mission is to disrupt every point in the Alzheimer’s patient journey and raise the standard of living for Alzheimer’s patients around the globe.